Unijules.com

Our Vision PDF Print E-mail

We believe that the pharmaceutical business is today poised for a great leap forward. Truly innovative technologies with the potential to change the nature of human health and longevity have already appeared and each day brings better and better innovations. At the same time, the fruits of these discoveries are becoming prohibitively unaffordable for the majority of the human race. There is a desperate need for solutions that emerge out of these innovative technologies to reach the common man at an affordable cost so that these benefits do not remain accessible only to the rich and affluent sections of society.

Image Ever changing regulatory guidelines, advance in drug therapy and delivery systems, drug industry mergers aquisitions, globalisation and evolving markets such as those for nutritional supplements, old age and alternative therapy medicines pose challenges to every pharmaceutical organisation to manage and accelerate the drug development process.

We, at UNIJULES, aspire to play a significant role in making the fruits of such technologies available as affordable healthcare solutions, teaming with like-minded associates in the pharmaceutical technology business, aiming for customer satisfaction, while respecting the rights of others.

Uniquely positioned to provide & expertised in new drug delivery systems, we support our own and customers objectives with specialised formulations to reach the market faster and easier than ever.

We are committed towards providing our national and international clients an easy and timely access to sophisticated process technologies and products, give value for money and to offer our customer innovative and exclusive quality products that differentiate them from their competitors and significantly impacts their bottom line.

That’s why, every day we continue to put our zeal for excellence and spirit of innovation into all our actions.

 
< Prev   Next >

R & D ACCREDITATION


UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Profile arrow Certifications arrow Our Vision
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.